Cubicin and Erythema multiforme - a phase IV clinical study of FDA data
Summary:
Erythema multiforme is reported as a side effect among people who take Cubicin (daptomycin), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Vancomycin, and have Staphylococcal infection.
The phase IV clinical study analyzes which people have Erythema multiforme when taking Cubicin. It is created by eHealthMe based on reports of 7,953 people who have side effects when taking Cubicin from the FDA, and is updated regularly.
What is Cubicin?
Cubicin has active ingredients of daptomycin. It is often used in infection. eHealthMe is studying from 7,991 Cubicin users. Check the latest studies of Cubicin.
What is Erythema multiforme?
Erythema multiforme (a type of hypersensitivity reaction) is found to be associated with 1,707 drugs and 2,920 conditions by eHealthMe. Check the latest studies of Erythema multiforme.
7,953 people reported to have side effects when taking Cubicin.
Among them, 65 people (0.82%) have Erythema multiforme.
Among these 65 people:
How long have people been on Cubicin when they have Erythema multiforme? *
- < 1 month: 91.89 %
- 1 - 6 months: 8.11 %
- 6 - 12 months: 0.0 %
- 1 - 2 years: 0.0 %
- 2 - 5 years: 0.0 %
- 5 - 10 years: 0.0 %
- 10+ years: 0.0 %
What is the gender of people who have Erythema multiforme when taking Cubicin? *
- female: 41.27 %
- male: 58.73 %
What is the age of people who have Erythema multiforme when taking Cubicin? *
- 0-1: 0.0 %
- 2-9: 6.78 %
- 10-19: 0.0 %
- 20-29: 1.69 %
- 30-39: 3.39 %
- 40-49: 13.56 %
- 50-59: 11.86 %
- 60+: 62.71 %
What are other drugs people take besides Cubicin? *
- Vancomycin: 23 people, 35.38%
- Lyrica: 8 people, 12.31%
- Cancidas: 8 people, 12.31%
- Lunesta: 6 people, 9.23%
- Nexium: 6 people, 9.23%
- Opdivo: 6 people, 9.23%
- Casodex: 6 people, 9.23%
- Piperacillin And Tazobactam: 4 people, 6.15%
- Valcyte: 3 people, 4.62%
- Paracetamol: 3 people, 4.62%
What are other side effects people have besides Erythema multiforme? *
- Staphylococcal Infection (an infection with staphylococcus bacteria): 8 people, 12.31%
- Acute Kidney Failure: 6 people, 9.23%
- Toxic Skin Eruption (skin breakdown due to toxic substance): 6 people, 9.23%
- Anaemia (lack of blood): 5 people, 7.69%
- Rashes (redness): 4 people, 6.15%
- Thrombocytopenia (decrease of platelets in blood): 4 people, 6.15%
- Hypogammaglobulinaemia (an abnormally low concentration of gamma globulin in the blood and increased risk of infection): 4 people, 6.15%
- Febrile Neutropenia (fever with reduced white blood cells): 4 people, 6.15%
- Renal Impairment (severely reduced kidney function): 4 people, 6.15%
- Hypotension (abnormally low blood pressure): 3 people, 4.62%
What are the existing conditions these people have? *
- Staphylococcal Infection (an infection with staphylococcus bacteria): 15 people, 23.08%
- Pain: 13 people, 20.00%
- Arthritis Bacterial (form of joint disorder that involves inflammation of one or more joints due to bacterial infection): 7 people, 10.77%
- Fever: 6 people, 9.23%
- Gastric Cancer (stomach cancer): 6 people, 9.23%
- Constipation: 6 people, 9.23%
- Device Related Infection: 5 people, 7.69%
- Fungal Infection: 4 people, 6.15%
- Systemic Inflammatory Response Syndrome (an inflammatory state affecting the whole body, frequently a response of the immune system to infection): 4 people, 6.15%
- Acute Lymphocytic Leukemia (All) (cancer of the white blood cells characterized by excess lymphoblasts): 4 people, 6.15%
* Approximation only. Some reports may have incomplete information.
Do you take Cubicin and have Erythema multiforme?
- Check whether Erythema multiforme is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Cubicin:
- Cubicin (7,991 reports)
Erythema multiforme treatments and more:
- Erythema multiforme (56,072 reports)
How severe was Erythema multiforme and when was it recovered:
Expand to all the drugs that have ingredients of daptomycin:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Cubicin:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Erythema multiforme:
- Erythema multiforme (1,707 drugs)
Browse all the conditions that are associated with Erythema multiforme:
- Erythema multiforme (2,920 conditions)
Related publications that referenced our studies
- Saliho?lu M, Turhan V, ?nem Y, Ulcay A, Uzun G, Ay H, "Sudden hearing loss in a patient receiving piperacillin/tazobactam and daptomycin for diabetic foot infection", Scandinavian journal of infectious diseases, 2013 Mar .
- Tognetti L, Giorgini S, Lotti T, "Erythema multiforme-like eruption from a slimming drug preparation cutaneous adverse drug reaction", Indian dermatology online journal, 2011 Jan .
- Saliho?lu M, Turhan V, ?nem Y, Ulcay A, Uzun G, Ay H, "Sudden hearing loss in a patient receiving piperacillin/tazobactam and daptomycin for diabetic foot infection", Scandinavian journal of infectious diseases, 2013 Mar .
- Tognetti L, Giorgini S, Lotti T, "Erythema multiforme-like eruption from a slimming drug preparation cutaneous adverse drug reaction", Indian dermatology online journal, 2011 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on daptomycin (the active ingredients of Cubicin) and Cubicin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Vitamins and Rhinocort Allergy - 4 seconds ago
- Could Velcade cause Hepatic Function Abnormal? - 10 seconds ago
- Could Tysabri cause Hepatic Encephalopathy? - 15 seconds ago
- Drug interactions of Provigil and Premarin - 17 seconds ago
- Drug interactions of Claforan and Cymbalta - 17 seconds ago
- Drug interactions of Cordarone and Tapazole - 17 seconds ago
- Drug interactions of Atrovent and Dexmedetomidine - 18 seconds ago
- Could Risperidone cause Posterior Reversible Encephalopathy Syndrome? - 19 seconds ago
- Drug interactions of Metoclopramide Hydrochloride and Enhertu - 23 seconds ago
- Drug interactions of Fioricet and Lioresal - 26 seconds ago